1. CAPRISA Advanced Clinical Care Presented by: Nesri Padayatchi
November 2015

2. Programme Goals and Objectives
To strengthen capacity of the South African Department of Health to provide quality and sustainable clinical care for HIV-infected patients with complicated HIV and HIV/TB treatment management, including 2nd and 3rd line and other antiretroviral therapy.

3. Health Systems Strengthening ART and TB Drug Resistance
Programme Overview
Training Program
Two day ACC Training special focus on Doctors & Pharmacists
Case-based & Interactive
IDU Specialist Trainers
District trainers
Health Systems Strengthening
File and Facility Audits for identification of gaps that contribute to ongoing morbidity and mortality
Strengthening Referral Pathways
Technology-based HCWs support /helplines
Distribution of Materials & Resources
DoH Transition
Regular engagement with DMT/RTC in developing and implementing activities
All training and HSS activities conducted with DMT and regional specialists to ensure sustainability
ART and TB Drug Resistance
Collaboration with NHLS
Surveillance on transmitted and acquired genotypic mutations conferring ART resistance in KwaZulu-Natal

4. HIV & TB Advanced Clinic Care Management Training Workshops
Didactic & Interactive Case-based Training
- 2 day Complex HIV and TB Management Workshop
- Ad hoc Trainings as requested by the District DoH
Trainers/Speakers
- Majority of speakers are DoH staff members
- District doctors encouraged to present sessions
- Specialist IDU Physicians invited as Trainers
Distribution of Guidelines, Dosing charts and Algorithms
- Pocket-sized version of current HIV and TB Treatment guidelines
- Opportunity to advertise helplines (MDR TB, Paediatric, NHLS)
- Distribution of GXP algorithm, paediatric dosing chart

5. Acknowledgements
This programme is supported by the Grant or Cooperative Agreement Number U2G GH001142, funded by the Centres for Disease Control and Prevention. Its contents are solely the responsibility of the presenter(s) and do not necessarily represent the official views of the U.S. Centres for Disease Control and Prevention or the U.S. Department of Health and Human Services